Gapping up
In reaction to strong earnings/guidance: ELMD +46.6%, AKAM +18%, LLNW+17.8%, PAYC +15.6%, CRTO +15.2%, PSEC +11.2%, MKTO +9.9%, FDC+8.1%, RSYS +7.9%, UNIS +7.7%, ATEN +7.3%, NUAN +5.9%, SCSC +5.4%,SGMO +5.1%, PNRA +3.4%, GWPH +3%, USAC +2.9%, CG +2.7%, TCX+1.5%, RICK +1.5%, FWRD +1.2%, TWX +0.6%
M&A news: EDE +15.2% (Empire District Elec to be acquired by Algonquin Power & Utilities for $34/share, or ~$2.4 bln)
Select financial related names showing strength: DB 8% (co is considering a multi-billion euro bond buyback), BBVA 5.4%, SAN 5%, CS 2.1%, C 2.1%
Other news: FIT +3.8% (Salesforce.com's (CRM) Marc R. Benioff discloses 5.3% passive stake ), RACE +3.5% (cont pre-mkt vol), QGEN +2% (Qiagen & 10x Genomics to enter into Co-marketing and co-development collaboration), SHPG +2% (granted orphan designation by the FDA for its compound for the treatment of retinitis pigmentosa), JOY +1.9% (still checking), TWTR +1.7% (reports earnings AMC), NOK +1.4% (publishes results for its public exchange offer for Alcatel-Lucent (ALU); Nokia to hold ~91% of the share capital of ALU)
Analyst comments: RBS +5.4% (upgraded to Outperform from Underperform at Exane BNP Paribas+), BUD +3.9% (upgraded to Buy from Neutral at BTIG Research), NFLX +2.1% (upgraded to Buy from Outperform at Credit Agricole ), HES +1.3% (added to Conviction Buy List at Goldman), SYT +0.6% (upgraded to Buy at Kepler)
In reaction to strong earnings/guidance: ELMD +46.6%, AKAM +18%, LLNW+17.8%, PAYC +15.6%, CRTO +15.2%, PSEC +11.2%, MKTO +9.9%, FDC+8.1%, RSYS +7.9%, UNIS +7.7%, ATEN +7.3%, NUAN +5.9%, SCSC +5.4%,SGMO +5.1%, PNRA +3.4%, GWPH +3%, USAC +2.9%, CG +2.7%, TCX+1.5%, RICK +1.5%, FWRD +1.2%, TWX +0.6%
M&A news: EDE +15.2% (Empire District Elec to be acquired by Algonquin Power & Utilities for $34/share, or ~$2.4 bln)
Select financial related names showing strength: DB 8% (co is considering a multi-billion euro bond buyback), BBVA 5.4%, SAN 5%, CS 2.1%, C 2.1%
Other news: FIT +3.8% (Salesforce.com's (CRM) Marc R. Benioff discloses 5.3% passive stake ), RACE +3.5% (cont pre-mkt vol), QGEN +2% (Qiagen & 10x Genomics to enter into Co-marketing and co-development collaboration), SHPG +2% (granted orphan designation by the FDA for its compound for the treatment of retinitis pigmentosa), JOY +1.9% (still checking), TWTR +1.7% (reports earnings AMC), NOK +1.4% (publishes results for its public exchange offer for Alcatel-Lucent (ALU); Nokia to hold ~91% of the share capital of ALU)
Analyst comments: RBS +5.4% (upgraded to Outperform from Underperform at Exane BNP Paribas+), BUD +3.9% (upgraded to Buy from Neutral at BTIG Research), NFLX +2.1% (upgraded to Buy from Outperform at Credit Agricole ), HES +1.3% (added to Conviction Buy List at Goldman), SYT +0.6% (upgraded to Buy at Kepler)